D. L. LEIKER

433 total citations
40 papers, 294 citations indexed

About

D. L. LEIKER is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, D. L. LEIKER has authored 40 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 15 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in D. L. LEIKER's work include Leprosy Research and Treatment (25 papers), Mycobacterium research and diagnosis (12 papers) and Infectious Diseases and Tuberculosis (7 papers). D. L. LEIKER is often cited by papers focused on Leprosy Research and Treatment (25 papers), Mycobacterium research and diagnosis (12 papers) and Infectious Diseases and Tuberculosis (7 papers). D. L. LEIKER collaborates with scholars based in Netherlands, Ethiopia and Cuba. D. L. LEIKER's co-authors include W. R. Faber, Willem van Eden, RenéR.P. de Vries, Jon J. van Rood, J. D‘Amaro, I. Schreuder, Hennicke Kamp, Abebe Haregewoin, Michael F. Waters and Tore Godal and has published in prestigious journals such as Infection and Immunity, Immunological Reviews and Human Immunology.

In The Last Decade

D. L. LEIKER

33 papers receiving 229 citations

Peers

D. L. LEIKER
J. W. Millar United Kingdom
D. L. LEIKER
Citations per year, relative to D. L. LEIKER D. L. LEIKER (= 1×) peers J. W. Millar

Countries citing papers authored by D. L. LEIKER

Since Specialization
Citations

This map shows the geographic impact of D. L. LEIKER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. L. LEIKER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. L. LEIKER more than expected).

Fields of papers citing papers by D. L. LEIKER

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. L. LEIKER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. L. LEIKER. The network helps show where D. L. LEIKER may publish in the future.

Co-authorship network of co-authors of D. L. LEIKER

This figure shows the co-authorship network connecting the top 25 collaborators of D. L. LEIKER. A scholar is included among the top collaborators of D. L. LEIKER based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. L. LEIKER. D. L. LEIKER is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamp, Hennicke, et al.. (1998). The relation between the lucio phenomenon and cutaneous allergic vasculitis (Ruiter). Report of two imported cases of necrotizing vasculitis in lepromatous patients seen in the Netherlands.. PubMed. 30. 138–51. 3 indexed citations
2.
LEIKER, D. L., et al.. (1998). Lepromin vs purified bacillus suspension II. Comparative tests with a purified bacillus suspension.. PubMed. 30. 27–47.
3.
LEIKER, D. L., et al.. (1996). GRANULOMA MULTIFORME, A NEW SKIN DISEASE RESEMBLING LEPROSY.. PubMed. 32. 368–76. 2 indexed citations
4.
Lombardi, Carlo, Samuel Cohen, D. L. LEIKER, et al.. (1994). Agreement between histopathological results in clinically diagnosed cases of indeterminate leprosy in São Paulo, Brazil.. PubMed. 9(2). 83–8. 2 indexed citations
5.
Grosset, J, C. Hupin, D. L. LEIKER, et al.. (1992). Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone?. 60(4). 536–541. 1 indexed citations
7.
Colston, M. Joseph, G.A. Ellard, J Grosset, et al.. (1988). Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Leprosy Review. 59(1). 5–10.
8.
Haregewoin, Abebe, et al.. (1984). Reversal by Interleukin‐2 of the T Cell Unresponsiveness of Lepromatous Leprosy to Mycobacterium Leprae. Immunological Reviews. 80(1). 77–86. 30 indexed citations
9.
Zuidema, J., et al.. (1982). Intramuscular injection of dapsone in therapy for leprosy: a new approach.. PubMed. 20(2). 51–6. 1 indexed citations
10.
Eggelte, Teunis A., et al.. (1981). ELISA inibition technique for the demonstration of sulphones in body fluids. Comparison of two ELISA methods. Leprosy Review. 52(3). 215–20. 3 indexed citations
11.
LEIKER, D. L., et al.. (1981). ELISA inhibition technique for the demonstration of sulphones in body fluids. II. A new method to monitor leprosy patient compliance under field conditions.. PubMed. 52(1). 11–8. 5 indexed citations
12.
Faber, W. R. & D. L. LEIKER. (1979). Evaluation of Treatment of Lepromatous Leprosy Patients in The Netherlands. Dermatology. 158(1). 46–54. 1 indexed citations
13.
Eggelte, Teunis A., et al.. (1979). ELISA Inhibition Technique for the Demonstration of Sulphones in Body Fluids I. Sulphones Specific Antibody-enzyme Conjugate. Leprosy Review. 50(4). 275–81. 4 indexed citations
15.
LEIKER, D. L.. (1975). CHEMOTHERAPY IN LEPROSY. International Journal of Dermatology. 14(4). 254–262. 3 indexed citations
16.
Verhagen, A.R.H.B., et al.. (1968). Leprosy in Kenya.. PubMed. 45(6). 371–7. 3 indexed citations
17.
LEIKER, D. L., et al.. (1967). Granuloma multiforme in Kenya.. PubMed. 44(10). 429–36. 6 indexed citations
18.
LEIKER, D. L.. (1961). Studies on the Lepromin Test. II. Time of Reading and Ulcération of the Lepromin Reaction.. 29(2). 1 indexed citations
19.
LEIKER, D. L.. (1961). Studies on the Lepromin Test. I. The Influence of the Bacillary and Tissue Components in Dilutions of Lepromin.. 29(2). 3 indexed citations
20.
LEIKER, D. L.. (1960). LEPROSY IN THE NETHERLANDS. Leprosy Review. 31(4). 290–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026